Tokai Pharmaceuticals


Tokai Pharmaceuticals is dedicated to developing innovative therapies for cancer patients, with a focus on prostate cancer and other hormonally-driven diseases. Their lead drug candidate, galeterone, is being evaluated in clinical trials for its effectiveness in treating castration-resistant prostate cancer by disrupting androgen receptor signaling.

Tokai Pharmaceuticals

Tokai Pharmaceuticals

One Broadway, 14th floor, Cambridge, MA 02142


Portfolio

Ablaze Pharmaceuticals is part of Vivo Capital's portfolio, focusing on innovative healthcare solutions.

#Pharmaceuticals

Aligos Therapeutics is involved in developing therapies for liver diseases and viral infections.

#Biopharmaceuticals

Actelion focuses on innovative treatments for pulmonary arterial hypertension.

#Biopharmaceuticals

Lepu Biopharma focuses on oncology therapeutics and successfully listed on the HKEX.

#Biopharmaceuticals

Lepu ScienTech focuses on interventional medical devices for structural heart disease and has a significant market share in China.

#Medical Technology

Zogenix was acquired by UCB, focusing on therapies for rare diseases.

#Biopharmaceuticals

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.